Skip to main content

Human embryos were just edited in the U.S. for the first time

human embryo
Last week, a team of researchers in Portland, Oregon, carried out the first known attempt at genetically modifying human embryos in the U.S. by way of CRISPR gene-editing technology. As initially reported by the Massachusetts Institute of Technology (MIT) Technology Review, the project involved editing the DNA of several one-cell embryos, and was led by Shoukhrat Mitalipov of Oregon Health and Science University.

Previously, other attempts at editing human embryos had been carried out exclusively in other countries. Thus far, three other reports of this sort of genetic modification have all come out of China. However, this latest experiment is said to be revolutionary in its own right, both in the number of embryos involved in the work, and in the demonstration that human embryos can be modified in order to “correct defective genes that cause inherited diseases.”

Related Videos

Mitalipov is no stranger to the spotlight, nor to controversy. The scientist is also the first to have cloned embryonic stem cells in humans, as well as the mind behind three-parent in-vitro fertilization. He’s also worked in China when restrictions in the U.S. became too, well, restrictive for his work. And of course, editing human embryos is no less controversial than anything else he’s done.

None of the modified embryos was given the time to develop for more than a few days, and Mitalipov’s team claims that there was “never any intention of implanting them into a womb.” Rather, the work was done to determine what is possible when it comes to genetically modifying people. The hope is to prove that modern science and medicine can either erase or mend genes responsible for inherited disease, but critics note that, once the technology is developed, it could be used for other purposes.

Previous attempts at using CRISPR on human embryos were not fully successful, as certain editing errors occurred and DNA changes were not adopted by all the cells of an embryo. However, Mitalipov’s team appears to have found a way to circumvent those problems.

That said, there are skeptics who fear that this kind of work opens up the door for designer babies, and the U.S. intelligence community went so far last year as to call CRISPR a potential “weapon of mass destruction.”

Regardless, the work is a major breakthrough in the genetics field, though how it will ultimately be implemented is yet to be determined.

Editors' Recommendations

HMD Global shows its serious about U.S. expansion with 5 new Nokia phones
HMD Global's range of new Nokia phones at CES 2022.

HMD Global has big plans for the U.S. market, and at CES 2022 it has revealed a new range of devices that cost less than $250, all coming out over the next months. Buoyed by LG and ZTE both leaving the U.S., it has struck lucrative deals with T-Mobile, Tracfone, Verizon, and other carriers to supply Nokia phones on pre-paid contracts, including low-cost feature phones.

To help achieve its ambitious targets in the U.S. for the coming year -- it's targeting number one in feature phones, and number three in pre-paid smartphones -- it has announced five new U.S. exclusive phones that will arrive during the first six months of the year. Top of the list is an affordable 5G phone, followed by three 4G phones, and a new feature phone with Kai OS software onboard.

Read more
Toyota announces site for its first U.S. battery plant
2019 Toyota Corolla hatchback

Toyota is doubling down on its electric vehicle ambitions with the building of a $1.3 billion battery production plant in North Carolina, its first such facility in the U.S.

The Japanese automaker announced the plan on Monday, December 6, revealing that it will build the plant in the Greensboro-Randolph area about 80 miles northeast of Charlotte.

Read more
iPhone 13 and Z Flip 3 keep Apple and Samsung sales strong in U.S. and Europe
Galaxy Z Flip 3 closed with Cover Screen active.

The smartphone markets in the U.S. and Europe are still suffering from a chip shortage, according to a report from Counterpoint Research, with overall sales being slightly lower in Europe and slightly higher in the U.S. than they were last year. In Europe, Samsung, Xiaomi, and Apple led the European smartphone market in Q3 (July, August, and September). Even though Samsung saw a decline from the immediately preceding quarter, the newly launched Galaxy Z Flip 3 helped its fortunes. The U.S. market remains dominated by Apple and Samsung, with Motorola continuing slow and steady growth.

Zooming out to look at the bigger picture, aside from Apple, the usual suspects who make the best Android phones (Samsung, Xiaomi, Oppo) lead the pack in the European market. This was likely with phones like the Galaxy Z Flip 3 and OnePlus 9, along with lower-priced A-Series models, while there are some surprise entrants from the likes of Vivo and Realme. Huawei continues to decline, with the lack of Google services and the limited launch of the P50 continuing to take their toll, while former sub-brand Honor is on the rise. The company just launched the Honor 50 and Honor 50 Pro as its first phones with Google services in years, and it'll be interesting to see how these affect future sales.

Read more